Roxana Mehran, MD

img_Roxana Mehran
PROFESSOR | Medicine, Cardiology
PROFESSOR | Population Health Science and Policy
Are you a patient?
Specialties
Cardiology (Heart), Cardiovascular Disease (Heart Disease)

MD, St. George's University School of Medicine

Residency, Internal Medicine, InterCommunity Health Care

Residency, Internal Medicine, University of Connecticut Health

Fellowship, Cardiovascular Disease, Mount Sinai Hospital

Fellowship, Interventional Cardiology, Mount Sinai Hospital

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Design of VICTORION-2 Prevent: A randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascular disease. Philippe Gabriel Steg, Shaun G. Goodman, Johan Wouter Jukema, Pieter Martens, Andreas Zirlik, Deepak L. Bhatt, Venu Menon, Michael Szarek, Anastasia Lesogor, Christian Stratz, Fintan O’Donoghue, Jorge Mena-Madrazo, Qing Shao, Karen Liu, Roxana Mehran. American Heart Journal

Potentially futile outcome after uncomplicated TAVI: Insights from the TRITAVI registry. Fabrizio D’Ascenzo, Ovidio De Filippo, Francesco Pelliccia, Vincenzo Pasceri, George Dangas, Roxana Mehran, Italo Porto, Francesco Radico, Fausto Biancari, Francesco Saia, Giampaolo Luzi, Francesco Bedogni, Ignacio J.Amat Santos, Vincenzo De Marzo, Arnaldo Dimagli, Timo Mäkikallio, Samuele Sandrone, Eugenio Stabile, Sara B․-Turrión, Luca Testa, Marco Barbanti, Giuliano Costa, Franco Fabbiocchi, Ahmed Chilmeran, Giulio Stefanini, Federico Conrotto, Corrado Tamburino, Carmen Spaccarotella, Davide Cao, Andrea Macchione, Michele La Torre, Francesco Bendandi, Wojciech Wańha, Wojtek Wojakowski, Umberto Benedetto, Ciro Indolfi, David Hildick-Smith, Davide Capodanno, Fabio Miraldi, Dobromir Dobrev, Marco Zimarino. American Heart Journal

Secondary prevention strategies for patients with lower extremity peripheral artery disease after successful peripheral vascular intervention. Pishoy Gouda, Eric A. Secemsky, Connie N. Hess, Shipra Arya, Foluso Fokorede, Roxana Mehran, Marc P. Bonaca, Manesh R. Patel, William Schuyler Jones. American Heart Journal

View All Publications

DAPT and Triple Therapy: Updates on Latest Evidence for Patients with CAD Undergoing PCI

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Mehran has not yet completed reporting of industry relationships or has no industry relationships to report.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.